Reducing Use of Antibiotics without a Prescription among Outpatients in a Safety Net Healthcare System

在安全网医疗系统中减少门诊患者非处方抗生素的使用

基本信息

  • 批准号:
    10379940
  • 负责人:
  • 金额:
    $ 48.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-07-01 至 2024-04-30
  • 项目状态:
    已结题

项目摘要

Non-prescription antibiotic use is an understudied problem, prevalent in some low-income communities. This practice includes obtaining and taking antibiotics without a prescription (e.g., from ethnic stores or flea markets), taking another person's antibiotics, or taking one's own stored antibiotics for an indication other than that for which the antibiotic was originally prescribed. In our survey of low-income primary care patients in a large urban area, respondents from public clinics were more likely than respondents from private clinics to report intention to use antibiotics without a prescription. This survey generated considerable press interest, as the problem has barely been described in the United States, but we did not explore why the non-prescription use was occurring. Non-prescription use increases the risk of development of antibiotic resistance, adverse drug reactions, damage to the microbiome, and other harms. There is a critical need to identify the predictors of non-prescription use that will guide development of effective antimicrobial stewardship interventions in low- income populations, given that these populations are at higher risk of developing antibiotic-resistant infections. The overall objectives of the proposed project are to identify the predictors of non-prescription antibiotic use in diverse, predominantly uninsured patients of safety net clinics and lay the foundation for a subsequent intervention. We will use mixed methods and the Kilbourne et al. (2006) conceptual framework for advancing health disparities research to identify the predictors of non-prescription use. In Aim 1 (quantitative phase), we will administer a survey in Spanish and English to assess how patient (e.g., health literacy), health care system (e.g., access to care), and clinical encounter factors (patient-provider communication) are associated with non- prescription antibiotic use in low-income patients. In Aim 2 (qualitative phase), using in-depth interviews, we will explore patient perspectives and experiences with non-prescription use among a racially/ethnically diverse subsample of survey respondents who reported using antibiotics without a prescription. In Aim 3 (development of a communication tool), we will integrate quantitative and qualitative results into a communication tool to be used in the clinics to steer patients toward safer antibiotic use and healthcare options. Our team includes an epidemiologist, an infectious diseases physician, a health disparities researcher, health communications experts, and a medical anthropologist. This multidisciplinary team will work with a Community Advisory Board comprised of patient representatives from participating clinics. Our work will be guided by input from a representative from the Centers for Disease Control and Prevention and two health literacy consultants, one of whom is bilingual. The proposed research is innovative, because it will provide comprehensive understanding of the predictors of this unsafe use of antibiotics in a low-income population. The research is significant, because it will inform understanding of disparities in use of antibiotics and future development of interventions to reduce harms associated with non-prescription use, such as the spread of antibiotic-resistant bacteria.
非处方抗生素的使用是一个未充分研究的问题,在一些低收入社区普遍存在。这

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Larisa Grigoryan其他文献

Larisa Grigoryan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Larisa Grigoryan', 18)}}的其他基金

A Randomized Controlled Trial of a Diagnostic Stewardship Intervention to Reduce Inappropriate Antibiotic Use for Urinary Tract Infections in Primary Care
一项诊断管理干预措施的随机对照试验,以减少初级保健中尿路感染的不当抗生素使用
  • 批准号:
    10716759
  • 财政年份:
    2023
  • 资助金额:
    $ 48.87万
  • 项目类别:
Reducing Use of Antibiotics without a Prescription among Outpatients in a Safety Net Healthcare System
在安全网医疗系统中减少门诊患者非处方抗生素的使用
  • 批准号:
    9796626
  • 财政年份:
    2019
  • 资助金额:
    $ 48.87万
  • 项目类别:
Reducing Use of Antibiotics without a Prescription among Outpatients in a Safety Net Healthcare System
在安全网医疗系统中减少门诊患者非处方抗生素的使用
  • 批准号:
    10609827
  • 财政年份:
    2019
  • 资助金额:
    $ 48.87万
  • 项目类别:

相似海外基金

Evaluating the effectiveness and implementation process of population-level interventions to reduce inappropriate use of antibiotics in primary care settings to inform policy development in Canada
评估人口层面干预措施的有效性和实施过程,以减少初级保健机构中抗生素的不当使用,为加拿大的政策制定提供信息
  • 批准号:
    477887
  • 财政年份:
    2023
  • 资助金额:
    $ 48.87万
  • 项目类别:
    Operating Grants
How can guidelines be optimised to help achieve the rational use of antibiotics after the Covid-19 pandemic?
如何优化指南以帮助实现 Covid-19 大流行后合理使用抗生素?
  • 批准号:
    2587230
  • 财政年份:
    2021
  • 资助金额:
    $ 48.87万
  • 项目类别:
    Studentship
SBIR Phase I: Development of point-of-care diagnostics to direct the appropriate use of antibiotics for the treatment of high-risk urinary tract infections
SBIR 第一阶段:开发即时诊断,指导正确使用抗生素治疗高危尿路感染
  • 批准号:
    2014629
  • 财政年份:
    2020
  • 资助金额:
    $ 48.87万
  • 项目类别:
    Standard Grant
Potential use of white spruce foliar endophtyes as antibiotics in pharmacology
白云杉叶内生菌作为抗生素在药理学中的潜在用途
  • 批准号:
    554301-2020
  • 财政年份:
    2020
  • 资助金额:
    $ 48.87万
  • 项目类别:
    University Undergraduate Student Research Awards
Reducing Use of Antibiotics without a Prescription among Outpatients in a Safety Net Healthcare System
在安全网医疗系统中减少门诊患者非处方抗生素的使用
  • 批准号:
    9796626
  • 财政年份:
    2019
  • 资助金额:
    $ 48.87万
  • 项目类别:
Identifying the measures of appropriate antimicrobial use through the evaluation of selective pressure of antibiotics
通过评估抗生素的选择压力来确定适当的抗菌药物使用措施
  • 批准号:
    19K10573
  • 财政年份:
    2019
  • 资助金额:
    $ 48.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Reducing Use of Antibiotics without a Prescription among Outpatients in a Safety Net Healthcare System
在安全网医疗系统中减少门诊患者非处方抗生素的使用
  • 批准号:
    10609827
  • 财政年份:
    2019
  • 资助金额:
    $ 48.87万
  • 项目类别:
Insects as models to study the impact of antibiotics and microbiota therapies on the human gut microbiome: reducing the use of animals in research
以昆虫为模型研究抗生素和微生物疗法对人类肠道微生物组的影响:减少研究中动物的使用
  • 批准号:
    2223805
  • 财政年份:
    2018
  • 资助金额:
    $ 48.87万
  • 项目类别:
    Studentship
Insects as models to study the impact of antibiotics and microbiota therapies on the human gut microbiome: reducing the use of animals in research
以昆虫为模型研究抗生素和微生物疗法对人类肠道微生物组的影响:减少研究中动物的使用
  • 批准号:
    NC/R001782/1
  • 财政年份:
    2018
  • 资助金额:
    $ 48.87万
  • 项目类别:
    Training Grant
Pharmacoepidemiological study for antibiotics use and long term effect on early childhood
抗生素使用及其对幼儿的长期影响的药物流行病学研究
  • 批准号:
    18K14980
  • 财政年份:
    2018
  • 资助金额:
    $ 48.87万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了